Low group | High group | P value | ||
---|---|---|---|---|
Characteristics | (N = 30) | (N = 30) | ||
Age (years) | < 50 | 10 | 12 | 0.592 |
≥50 | 20 | 18 | ||
Gender | Male | 16 | 18 | 0.602 |
Female | 14 | 12 | ||
HBsAg status | Negative | 22 | 23 | 0.766 |
Positive | 8 | 7 | ||
AFP (ng/ml) | < 400 | 12 | 7 | 0.165 |
≥400 | 18 | 23 | ||
PIVKA-II | < 50 | 13 | 9 | 0.284 |
≥50 | 17 | 21 | ||
Tumor multiplicity | Single | 19 | 16 | 0.432 |
Multiple | 11 | 14 | ||
Tumor diameter (cm) | ≤5 | 17 | 8 | 0.018* |
>5 | 13 | 22 | ||
Differentiation | Well to moderate | 19 | 15 | 0.297 |
Poor | 11 | 15 | ||
Lymph node metastasis | Negative | 19 | 10 | 0.019* |
Positive | 11 | 20 | ||
TNM stage | I + II | 18 | 10 | 0.038* |
III + IV | 12 | 20 | ||
MVI | Negative | 17 | 9 | 0.037* |
Positive | 13 | 21 |